Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ke-Wei Sun

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|April 15, 2024
[Bupleuri Radix-Paeoniae Radix Alba medicated plasma exerts effects on HepG2 hepatoma cells by regulating miR-1297/PTEN signaling axis]Lin Ding, Ruo-Yu Wang, Fan Zhang, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|April 7, 2017
Novel HBV mutations and their value in predicting efficacy of conventional interferonDa-Xian Wu, Xiao-Yu Fu, Guo-Zhong Gong, et al.
Molecular and Clinical Oncology|February 3, 2022
Expression of PD-L1 and CD4+ tumor-infiltrating lymphocytes predict survival in head and neck squamous cell carcinomaZe-Ming Fu, De-Jun Zhang, Ying-Yuan Guo, et al.
Zhong Xi Yi Jie He Xue Bao = Journal of Chinese Integrative Medicine|September 2, 2004
[Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B]Ping Liu, Yi-Yang Hu, Cheng Liu, et al.
World Journal of Gastroenterology|May 20, 2005
Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis BPing Liu, Yi-Yang Hu, Cheng Liu, et al.
Journal of Ethnopharmacology|August 6, 2022
Efficacy and safety of Fuzheng Huayu tablet on persistent advanced liver fibrosis following 2 years entecavir treatment: A single arm clinical objective performance criteria trialZhi-Min Zhao, Chuan-Wu Zhu, Jia-Quan Huang, et al.
Chinese Journal of Integrative Medicine|December 10, 2016
Effect of Shuanghu Qinggan Granule () and Yigan Yiqi Jieyu Granule () plus lamivudine on chronic hepatitis B patients: A randomized double-blind placebo-controlled trialYong-An Ye, De-Lu Tian, Jian Jiang, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|April 15, 2024
[Bupleuri Radix-Paeoniae Radix Alba medicated plasma exerts effects on HepG2 hepatoma cells by regulating miR-1297/PTEN signaling axis]Lin Ding, Ruo-Yu Wang, Fan Zhang, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|April 7, 2017
Novel HBV mutations and their value in predicting efficacy of conventional interferonDa-Xian Wu, Xiao-Yu Fu, Guo-Zhong Gong, et al.
Molecular and Clinical Oncology|February 3, 2022
Expression of PD-L1 and CD4+ tumor-infiltrating lymphocytes predict survival in head and neck squamous cell carcinomaZe-Ming Fu, De-Jun Zhang, Ying-Yuan Guo, et al.
Zhong Xi Yi Jie He Xue Bao = Journal of Chinese Integrative Medicine|September 2, 2004
[Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B]Ping Liu, Yi-Yang Hu, Cheng Liu, et al.
World Journal of Gastroenterology|May 20, 2005
Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis BPing Liu, Yi-Yang Hu, Cheng Liu, et al.
Journal of Ethnopharmacology|August 6, 2022
Efficacy and safety of Fuzheng Huayu tablet on persistent advanced liver fibrosis following 2 years entecavir treatment: A single arm clinical objective performance criteria trialZhi-Min Zhao, Chuan-Wu Zhu, Jia-Quan Huang, et al.
Chinese Journal of Integrative Medicine|December 10, 2016
Effect of Shuanghu Qinggan Granule () and Yigan Yiqi Jieyu Granule () plus lamivudine on chronic hepatitis B patients: A randomized double-blind placebo-controlled trialYong-An Ye, De-Lu Tian, Jian Jiang, et al.
Pageof 3